K191083

Substantially Equivalent

COMPLETE CONTROL System Gen2

Applicant: Coapt, LLC
Product code: GXY
Advisory panel: Neurology
Date received: 2019-04-24
Decision date: 2019-05-24
Decision: Substantially Equivalent
Clearance type: Special
Location: Chicago, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.